Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Concentric Medical Treats First Patient With Trevo System

Concentric Medical has reported that the first cases of acute ischemic stroke have been treated using its Trevo System, an easy-to-use thrombus retrieval system. The main component of the Trevo System is stentriever, a new retrieval device which removes clots that cause stroke.

Tommy Andersson, professor and head of Neurointervention at Karolinska University Hospital, said: “The new Trevo System was effective. The Trevo was also easy to use and this is key in being able to rapidly restore blood flow for patients suffering an acute ischemic stroke. I believe the Trevo System may represent a great advance in the treatment of this potentially devastating condition.”

The company claims that since 2004, its devices have been used in stroke patients worldwide. This experience has been incorporated into the design of the Trevo System to make thrombus removal an easier, faster and more predictable procedure.

Maria Sainz, president and CEO of Concentric Medical, said: “The Trevo System represents an opportunity for Concentric, one that has the potential to expand the treatment of stroke. As a leader in stroke intervention, we are committed to bring innovative tools to clinicians. We are also committed to offer the broadest range of interventional devices and systems to treat patients effectively.”

Concentric Medical currently markets the Merci Retriever, a solution for ischemic stroke intervention. In addition, Concentric’s DAC catheters are often used in the setting of ischemic stroke and other neurointerventional procedures.

Together, the Trevo System, the Merci Retriever, and the DAC family of catheters represent an array of choices for physicians involved in the treatment of ischemic stroke, said the company.